Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
- Conditions
- MultimorbidityContinuity of Care
- Registration Number
- NCT03697772
- Lead Sponsor
- University of Paris 5 - Rene Descartes
- Brief Summary
Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients
- Detailed Description
The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date.
This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study
- seen at home
- unable to respond (cognitive problems or language barrier)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method care pathway over the past 1 year the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database
Continuity of care over the past 1year Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)
- Secondary Outcome Measures
Name Time Method global quality of life over the past 1 year EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)
burden of traitement over the past 1 year Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)
Trial Locations
- Locations (1)
Université Paris Cité
🇫🇷Paris, France
Université Paris Cité🇫🇷Paris, France